EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Generating and using real-world data: A worthwhile uphill battle

K Verkerk, E E Voest

Cell · 2024

DOI: 10.1016/j.cell.2024.02.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell, 2024. Verfasst von K Verkerk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlan…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 155 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The precision oncology paradigm challenges the feasibility and data generalizability of traditional clinical trials. Consequently, an unmet need exists for practical approaches to test many subgroups, evaluate real-world drug value, and gather comprehensive, accessible datasets to validate novel biomarkers. Real-world data (RWD) are increasingly recognized to have the potential to fill this gap in research methodology. Established applications of RWD include informing disease epidemiology, pharmacovigilance, and healthcare quality assessment. Currently, concerns regarding RWD quality and comprehensiveness, privacy, and biases hamper their broader application. Nonetheless, RWD may play a pivotal role in supplementing clinical trials, enabling conditional reimbursement and accelerated drug access, and innovating trial conduct. Moreover, purpose-built RWD repositories may support the extension or refinement of drug indications and facilitate the discovery and validation of new biomarkers. This perspective explores the potential of leveraging RWD to advance oncology, highlights its benefits and challenges, and suggests a path forward in this evolving field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansPrecision MedicineMedical OncologyResearch DesignBiomarkers

Stichwörter der Autor:innen

oncologyprecision oncologyreal-world datareal-world evidence

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
  • Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX,…

Zitieren

APA

Verkerk, K., & Voest, E. E. (2024). Generating and using real-world data: A worthwhile uphill battle. Cell. https://doi.org/10.1016/j.cell.2024.02.012

Vancouver

Verkerk K, Voest EE. Generating and using real-world data: A worthwhile uphill battle. Cell. 2024. doi:10.1016/j.cell.2024.02.012

BibTeX
@article{Verkerk2024,
  author = {Verkerk, K and Voest, E E},
  title = {Generating and using real-world data: A worthwhile uphill battle},
  journal = {Cell},
  year = {2024},
  doi = {10.1016/j.cell.2024.02.012}
}
Kostenlos starten →